Max CBD 25 mg
En vente sur le marché américain (selon le DSLD)
Pure Prescriptions, food supplement from the US market
Max CBD 25 mg (Pure Prescriptions), a food supplement au code-barres 850021504069, is described by its US market label, recorded on 22 August 2024. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label, entered on 22 August 2024. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- À vérifier
Cannabidiol is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
Source: Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), POL-NF-00210.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Pure Prescriptions
- Barcode
- 850021504069
- Form
- Softgel
- One serving
- 1 softgel
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Medium Chain Triglyceride, Vitamin E Dimer Derivative, Monoglycerides, Diglycerides, Fatty Acids, Natural Flavors, Bovine Gelatin, Glycerin, Carob, Water
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| HempChoice BSHOE Hemp Oil Extract (Cannabis sativa) | Plant | 334 mg |
| Cannabidiol | Other substance | 25 mg |
| Beta-Caryophyllene | Other substance | 10 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Dreamtime CBD
Entered into DSLD on 22 August 2024. En vente sur le marché américain (selon le DSLD).- Active ingredient added : Melatonin (3 mg)
- Different quantity per serving : Beta-Caryophyllene: 4 mg in this version; 10 mg on the displayed label
- Different quantity per serving : Cannabidiol: 10 mg in this version; 25 mg on the displayed label
- Different quantity per serving : HempChoice BSHOE Hemp Oil Extract: 134 mg in this version; 334 mg on the displayed label
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : Pure Prescriptions